These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27498671)

  • 1. The power of two: an update on fixed-dose combinations for type 2 diabetes.
    Harris SB
    Expert Rev Clin Pharmacol; 2016 Nov; 9(11):1453-1462. PubMed ID: 27498671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fixed-dose combinations for treatment of type 2 diabetes mellitus.
    Blonde L; San Juan ZT
    Adv Ther; 2012 Jan; 29(1):1-13. PubMed ID: 22271157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of oral combination therapy for type 2 diabetes in primary care: Meeting individualized patient goals.
    Lavernia F; Adkins SE; Shubrook JH
    Postgrad Med; 2015; 127(8):808-17. PubMed ID: 26439384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of persistence and adherence between fixed-dose combinations and two-pill combinations in Japanese patients with type 2 diabetes.
    Nishimura R; Kato H; Kisanuki K; Oh A; Onishi Y; Guelfucci F; Shimasaki Y
    Curr Med Res Opin; 2019 May; 35(5):869-878. PubMed ID: 30460858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to select and combine oral agents for patients with type 2 diabetes mellitus.
    Chipkin SR
    Am J Med; 2005 May; 118 Suppl 5A():4S-13S. PubMed ID: 15850548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combine and conquer: advantages and disadvantages of fixed-dose combination therapy.
    Bell DS
    Diabetes Obes Metab; 2013 Apr; 15(4):291-300. PubMed ID: 23013323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety, Efficacy, and Bioavailability of Fixed-Dose Combinations in Type 2 Diabetes Mellitus: A Systematic Updated Review.
    Vijayakumar TM; Jayram J; Meghana Cheekireddy V; Himaja D; Dharma Teja Y; Narayanasamy D
    Curr Ther Res Clin Exp; 2017; 84():4-9. PubMed ID: 28761573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy with metformin plus vildagliptin in type 2 diabetes mellitus.
    Guarino E; Nigi L; Patti A; Fondelli C; Dotta F
    Expert Opin Pharmacother; 2012 Jun; 13(9):1377-84. PubMed ID: 22397507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycemic effectiveness and medication adherence with fixed-dose combination or coadministered dual therapy of antihyperglycemic regimens: a meta-analysis.
    Han S; Iglay K; Davies MJ; Zhang Q; Radican L
    Curr Med Res Opin; 2012 Jun; 28(6):969-77. PubMed ID: 22494018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DPP-4 inhibitor plus SGLT-2 inhibitor as combination therapy for type 2 diabetes: from rationale to clinical aspects.
    Scheen AJ
    Expert Opin Drug Metab Toxicol; 2016 Dec; 12(12):1407-1417. PubMed ID: 27435042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fixed-dose combination].
    Nagai Y
    Nihon Rinsho; 2015 Mar; 73(3):465-9. PubMed ID: 25812374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antidiabetic fixed-dose combination tablet for the management of type 2 diabetes].
    Sakane N
    Nihon Rinsho; 2012 Jan; 70(1):165-70. PubMed ID: 22413513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Is there any progress in the blood glucose lowering therapy of type 2 diabetes?].
    Winkler G
    Orv Hetil; 2014 Aug; 155(31):1215-20. PubMed ID: 25095281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective study of persistence, adherence, and health economic outcomes of fixed-dose combination vs. loose-dose combination of oral anti-diabetes drugs.
    Lokhandwala T; Smith N; Sternhufvud C; Sörstadius E; Lee WC; Mukherjee J
    J Med Econ; 2016; 19(3):203-12. PubMed ID: 26473990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review of adherence, treatment satisfaction and costs, in fixed-dose combination regimens in type 2 diabetes.
    Hutchins V; Zhang B; Fleurence RL; Krishnarajah G; Graham J
    Curr Med Res Opin; 2011 Jun; 27(6):1157-68. PubMed ID: 21466277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycemic targets and medication limitations for type 2 diabetes mellitus in the older adult.
    Thompson AM; Linnebur SA; Vande Griend JP; Saseen JJ
    Consult Pharm; 2014 Feb; 29(2):110-23. PubMed ID: 24513421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination Glucose-Lowering Therapy Plans in T2DM: Case-Based Considerations.
    Blonde L; Dipp S; Cadena D
    Adv Ther; 2018 Jul; 35(7):939-965. PubMed ID: 29777519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fixed-dose combination in management of type 2 diabetes mellitus: Expert opinion from an international panel.
    Kalra S; Das AK; Priya G; Ghosh S; Mehrotra RN; Das S; Shah P; Bajaj S; Deshmukh V; Sanyal D; Chandrasekaran S; Khandelwal D; Joshi A; Nair T; Eliana F; Permana H; Fariduddin MD; Shrestha PK; Shrestha D; Kahandawa S; Sumanathilaka M; Shaheed A; Rahim AA; Orabi A; Al-Ani A; Hussein W; Kumar D; Shaikh K
    J Family Med Prim Care; 2020 Nov; 9(11):5450-5457. PubMed ID: 33532378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects.
    Kim S; Jang IJ; Shin D; Shin DS; Yoon S; Lim KS; Yu KS; Li J; Zhang H; Liu Y; Brendel E; Blode H; Wang Y
    J Clin Pharm Ther; 2014 Aug; 39(4):424-31. PubMed ID: 24806030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to oral therapy for type 2 diabetes: opportunities for enhancing glycemic control.
    Bartels D
    J Am Acad Nurse Pract; 2004 Jan; 16(1):8-16. PubMed ID: 15008033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.